Grading of soft tissue sarcomas: From histological to molecular assessment

Pathology

Volumn 46, Issue 2, 2014, Pages 113-120

  Neuville, Agnes ^a,b   Chibon, Frédéric ^a   Coindre, Jean Michel ^a,b  

^a INSTITUT BERGONIÉ   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Grading; Molecular signature; Sarcoma

Indexed keywords

ARTICLE; CANCER GRADING; HUMAN; MORTALITY; PATHOLOGY; REPRODUCIBILITY; SARCOMA; SOFT TISSUE TUMOR; TIME;

HUMANS; NEOPLASM GRADING; REPRODUCIBILITY OF RESULTS; SARCOMA; SOFT TISSUE NEOPLASMS; TIME FACTORS;

EID: 84896787700     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000048     Document Type: Article

References (39)

1. Fletcher CDM, Bridge JA, Hogendoorn C.W., Mertens F., eds. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC, 2013.
2. Coindre JM. Grading of soft tissue sarcomas. Review and update. Arch Pathol Lab Med 2006; 130: 1448-53.
3. Coindre JM, Terrier P, Bui N.B., et al Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 1996; 14: 869-77.
4. Pisters PWT, Leung DHY, Woodruff J, et al Analysis of prognostic factors in 1041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996; 14: 1679-89.
5. Guillou L, Coindre JM, Bonichon F, et al Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997; 15: 350-62.
6. Chibon F, Lagarde P, Salas S., et al Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 2010; 16: 781-7.
7. Russell WO, Cohen J, Enzinger F., et al Clinical and pathological staging system for soft tissue sarcomas. Cancer 1977; 40: 1562-70.
8. Trojani M, Contesso G, Coindre J.M., et al Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of histopathological grading system. Int J Cancer 1984; 33: 37-42.
9. Costa J, Wesley RA, Glatstein E, et al The grading of soft tissue sarcomas: results of a clinicopathological correlation in a series of 163 cases. Cancer 1984; 53: 530-41.
10. van Unnik J.A., Coindre JM, Contesso G, et al Grading of soft tissue sarcomas: experience of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 1993; 29A: 2089-93.
11. Gustafson P, Akerman M, Alvegard TA, et al. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis: the SIN-system. Eur J Cancer 2003; 39: 1568-76.
12. Oliveira AM, Nascimento AG Grading in soft tissue tumors: principles and problems. Skeletal Radiol 2001; 30: 543-59.
13. Guillou L, Coindre JM How should we grade soft tissue sarcomas and what are the limitations? Pathol Case Review 1998; 3: 1-6.
14. Rubin BP, Cooper K, Fletcher CDM, et al Protocol for the examination of specimens from patients with tumors of soft tissue. October 2013. http://www.cap.org/apps/docs/committees/cancer/cancer-protocols/2013/ SoftTissue-13protocol-3120.pdf
15. Edge SB, Byrd DR, Compton C.C., et al AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag, 2010.
16. Golouh R, Bracko M. What is current practice in soft tissue sarcoma grading? Radiol Oncol 2001; 35: 47-52.
17. Coindre JM, Terrier P, Guillou L., et al Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-26.
18. Brown FM, Fletcher CD Problems in grading soft tissue sarcomas. Am J Clin Pathol 2000; 114: S82-9.
19. Deyrup AT, Weiss SW Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology 2006; 48: 42-50.
20. Fletcher CD, Gustafson P, Rydholm A., et al Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001; 19: 3045-50.
21. Deyrup AT, Haydon RC, Huo D, et al Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: an analysis of 92 cases. Cancer 2003; 98: 805-13.
22. Coindre JM, Trojani M, Contesso G., et al Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58: 306-9.
23. Welker JA, Henshaw RM, Jelinek J, et al The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses. Outcome analysis of 155 patients in a sarcoma referral center. Cancer 2000; 89: 2677-86.
24. Hoeber I, Spillane AJ, Fisher C, et al Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann Surg Oncol 2001; 8: 80-7.
25. Würl P., Kappler M, Meye A., et al Co-expression of survivin and TERTand risk of tumour-related death in patients with soft tissue sarcoma. Lancet 2002; 16: 943-5.
26. Nielsen TO, West RB Translating gene expression into clinical care: sarcomas as a paradigm. J Clin Oncol 2010; 28: 1796-805.
27. Lee YF, John M, Falconer A., et al A gene expression signature associated with metastatic outcome in human leiomyosarcomas. Cancer Res 2004; 15: 7201-4.
28. Francis P, Namlos HM, Müller C, et al Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics 2007; 8: 73.
29. Carter SL, Eklund AC, Kohane I.S., et al A signature of chromosomal intability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Med 2006; 38: 1043-8.
30. Lagarde P, Pérot G, Kauffmann A., et al Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res 2012; 18: 826-38.
31. Astolfi A, Nannini M, Pantaleo M.A., et al A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. Lab Invest 2010; 90: 1285-94.
32. Lagarde P, Pzybyl J, Brulard C., et al Chromosme instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. J Clin Oncol 2013; 31: 608-15.
33. Hasegawa T, Yamamoto S, Yokoyama R., et al Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer 2002; 95: 843-51.
34. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
35. Shi L, Reid LH, Jones W.D., et al The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechno. 2006; 24: 1151-61.
36. Shi L, Campbell G, Jones W.D., et al The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechno. 2010; 28: 827-38.
37. Beck AH, Weng Z, Witten D.M., et al 3'-end sequencing for expresion quantification (3SEQ) from archival tumor samples. PLoS One 2010; 5: e8768.
38. Sweeney RT, Zhang B, Zhu S.X., et al Desktop transcriptome sequencing from archival tissue to identify clinically relevant translocations. Am J Surg Pathol 2013; 37: 796-803.
39. Bertucci F, Finetti P, Sabatier R., et al The CINSARC signature. Prognostic and predictive of response to chemotherapy? Cell Cycle 2010; 9: 1-3.